A 72-year-old woman with atrial fibrillation, hypertension, and type 2 diabetes presents to your clinic. She has no history of stroke or systemic embolism. Canadian practice often uses a CHADS-65 approach to anticoagulation. Which statement best reflects appropriate stroke prevention management in this patient?